Cargando…

Characterization of in vivo metabolites in rat urine following an oral dose of masitinib by liquid chromatography tandem mass spectrometry

Masitinib (MST) is an orally administered drug that targets mast cells and macrophages, important cells for immunity, by inhibiting a limited number of tyrosine kinases. It is currently registered in Europe and USA for the treatment of mast cell tumors in dogs. AB Science announced that the European...

Descripción completa

Detalles Bibliográficos
Autores principales: Kadi, Adnan A., Amer, Sawsan M., Darwish, Hany W., Attwa, Mohamed W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953916/
https://www.ncbi.nlm.nih.gov/pubmed/29766296
http://dx.doi.org/10.1186/s13065-018-0429-y